Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6798890 | Journal of the American Academy of Child & Adolescent Psychiatry | 2011 | 10 Pages |
Abstract
This study does not demonstrate a benefit for the addition of risperidone in adolescents with anorexia nervosa during the weight-restoration phase of care. Clinical trial registration information-A Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Anorexia Nervosa, http://www.clinicaltrials.gov, NCT00140426.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Jennifer M.D., Jane Ph.D., Eric M.D., Swan M.S., Mindy B.A., Rick Ph.D., Teri Ph.D., Guido M.D., Marianne Z. M.D.,